Nova Patents
AT458008T

Human monoclonal antibodies to CTLA-4

Abstract

This record has no abstract on file.

Term

Term ended

Expired 23 December 2019, 6.8 years ago.

  1. Priority
  2. Filed
  3. Granted
  4. Expired
  5. Today

115 members in 41 offices

This recordMember, by publication datePriority claim31 more offices are in the list below

Priority claims2

Priority claims
DocumentOfficeKindDate
11364798United States of AmericaP
9930895United States of AmericaW

Members115

Family members, oldest first
DocumentOfficeKind
CA2356215A1CanadaA1
CA2619682A1CanadaA1
WO0037504A2World Intellectual Property Organization (WIPO)A2
AU2214900AAustraliaA
WO0037504A3World Intellectual Property Organization (WIPO)A3
WO0037504A9World Intellectual Property Organization (WIPO)A9
IS5974AIcelandA
NO20013147D0NorwayD0
NO20013147LNorwayL
NO20120398LNorwayL
AP2001002213A0African Regional Intellectual Property Organization (ARIPO)A0
EP1141028A2European Patent Office (EPO)A2
CZ20012349A3CzechiaA3
ID29991AIndonesiaA
KR20010099899ARepublic of KoreaA
BR9916853ABrazilA
SK9142001A3SlovakiaA3
TR2001001831T2TürkiyeT2
TR200101831T2TürkiyeT2
EA200100698A1Eurasian Patent Organization (EAPO)A1
CN1328571AChinaA
HU0104604A2HungaryA2
HU1300750D0HungaryD0
HUP0104604A2HungaryA2
BG105722ABulgariaA
IL143797A0IsraelA0
MXPA01006422AMexicoA
TR2002000735T2TürkiyeT2
TR200200735T2TürkiyeT2
PL349266A1PolandA1
HRP20010551A2CroatiaA2
JP2002537226AJapanA
EE200100336AEstoniaA
ZA200105742BSouth AfricaB
US6682736B1United States of AmericaB1
NZ512553ANew ZealandA
AU772676B2AustraliaB2
US2004228858A1United States of AmericaA1
US2004228861A1United States of AmericaA1
CR6425ACosta RicaA
JP2005087215AJapanA
GEP20053594BGeorgiaB
KR20050084520ARepublic of KoreaA
US2005287136A1United States of AmericaA1
AP1590AAfrican Regional Intellectual Property Organization (ARIPO)A
OA11917AAfrican Intellectual Property Organization (OAPI)A
EA006972B1Eurasian Patent Organization (EAPO)B1
JP3793693B2JapanB2
KR100617337B1Republic of KoreaB1
US7109003B2United States of AmericaB2
UA76936C2UkraineC2
IL143797AIsraelA
US7132281B2United States of AmericaB2
KR20070086897ARepublic of KoreaA
SG143018A1SingaporeA1
CU23292B7CubaB7
CR9972ACosta RicaA
KR100849443B1Republic of KoreaB1
US7411057B2United States of AmericaB2
KR100856446B1Republic of KoreaB1
US2008233116A1United States of AmericaA1
US2008233122A1United States of AmericaA1
EP2112166A2European Patent Office (EPO)A2
SG156547A1SingaporeA1
EP1141028B1European Patent Office (EPO)B1
AT458008TThis recordAustriaT
ATE458008T1AustriaT1
DE69942037D1GermanyD1
BG65899B1BulgariaB1
PT1141028EPortugalE
DK1141028T3DenmarkT3
SI1141028T1SloveniaT1
ES2340745T3SpainT3
US7807797B2United States of AmericaB2
US7824679B2United States of AmericaB2
RS51309BSerbiaB
IS8950AIcelandA
CZ302706B6CzechiaB6
EE05483B1EstoniaB1
PL210435B1PolandB1
US2012045442A1United States of AmericaA1
US8143379B2United States of AmericaB2
US2012148597A1United States of AmericaA1
EE201200006AEstoniaA
IS2798BIcelandB
HU0104604A3HungaryA3
HUP0104604A3HungaryA3
NO332618B1NorwayB1
EE05627B1EstoniaB1
SK288057B6SlovakiaB6
EP2112166A3European Patent Office (EPO)A3
CZ303703B6CzechiaB6
HRP20010551B1CroatiaB1
PL214003B1PolandB1
US8491895B2United States of AmericaB2
HRP20130077A2CroatiaA2
HU229566B1HungaryB1
US2014099325A1United States of AmericaA1
US8883984B2United States of AmericaB2
US2015104409A1United States of AmericaA1
Showing 100 of 115